Unraveling the photoluminescence response of light-switching ruthenium(II) complexes bound to amyloid-β.

Photoluminescent molecules are widely used for real-time monitoring of peptide aggregation. In this Article, we detail both experimental and computational modeling to elucidate the interaction between [Ru(bpy)2dppz](2+) and amyloid-β (Aβ(1-40)) aggregates. The transition from monomeric to fibrillar Aβ is of interest in the study of Alzheimer's disease. Concentration-dependent experiments allowed the determination of a dissociation constant of 2.1 μM, while Job plots provided a binding stoichiometry of 2.6 Aβ monomers per [Ru(bpy)2dppz](2+). Our computational approach that combines molecular docking (both rigid and flexible) and all-atom molecular dynamics (MD) simulations predicts that the hydrophobic cleft between Val18 and Phe20 is a plausible binding site, which could also explain the increase in photoluminescence of [Ru(bpy)2dppz](2+) upon binding. This binding site is parallel to the fibril axis, in marked contrast to the binding site of these complexes in DNA (perpendicular to the DNA axis). Other binding sites may exist at the edges of the Aβ fibril, but they are actually of low abundance in an Aβ fibril several micrometers long. The assignment of the binding site was confirmed by binding studies in an Aβ fragment (Aβ(25-35)) that lacked the amino acids necessary to form the binding site. The agreement between the experimental and computational work is remarkable and provides a general model that can be used for studying the interaction of amyloid-binding molecules to Aβ.

[1]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[2]  P. Lincoln,et al.  Lifetime heterogeneity of DNA-bound dppz complexes originates from distinct intercalation geometries determined by complex-complex interactions. , 2013, Inorganic chemistry.

[3]  Laura Segatori,et al.  Detection of α-synuclein amyloidogenic aggregates in vitro and in cells using light-switching dipyridophenazine ruthenium(II) complexes. , 2012, Journal of the American Chemical Society.

[4]  Justin A. Lemkul,et al.  The role of molecular simulations in the development of inhibitors of amyloid β-peptide aggregation for the treatment of Alzheimer's disease. , 2012, ACS chemical neuroscience.

[5]  Chun Wu,et al.  Binding of Congo red to amyloid protofibrils of the Alzheimer Aβ(9-40) peptide probed by molecular dynamics simulations. , 2012, Biophysical journal.

[6]  J. Barton,et al.  Crystal structure of Δ-[Ru(bpy)2dppz]2+ bound to mismatched DNA reveals side-by-side metalloinsertion and intercalation , 2012, Nature Chemistry.

[7]  A. Middelberg,et al.  Molecular insight into conformational transition of amyloid β-peptide 42 inhibited by (-)-epigallocatechin-3-gallate probed by molecular simulations. , 2011, The journal of physical chemistry. B.

[8]  A. Martí,et al.  Sensing amyloid-β aggregation using luminescent dipyridophenazine ruthenium(II) complexes. , 2011, Journal of the American Chemical Society.

[9]  David Eisenberg,et al.  Towards a Pharmacophore for Amyloid , 2011, PLoS biology.

[10]  Joan-Emma Shea,et al.  On the origin of the stronger binding of PIB over thioflavin T to protofibrils of the Alzheimer amyloid-β peptide: a molecular dynamics study. , 2011, Biophysical journal.

[11]  A. Ewing,et al.  Ruthenium(II) Complex Enantiomers as Cellular Probes for Diastereomeric Interactions in Confocal and Fluorescence Lifetime Imaging Microscopy. , 2011, The journal of physical chemistry letters.

[12]  A. Martí,et al.  Non-covalent ruthenium polypyridyl complexes-carbon nanotubes composites: an alternative for functional dissolution of carbon nanotubes in solution. , 2011, Chemical communications.

[13]  Neil J. Bruce,et al.  Molecular dynamics simulations of Aβ fibril interactions with β-sheet breaker peptides , 2010, Peptides.

[14]  Justin A. Lemkul,et al.  Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations. , 2010, Biochemistry.

[15]  C. Turro,et al.  Efficient DNA photocleavage by [Ru(bpy)2(dppn)]2+ with visible light. , 2010, Chemical communications.

[16]  M. Groenning Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils—current status , 2010, Journal of chemical biology.

[17]  H. Gutiérrez‐de‐Terán,et al.  Crystal structure of thioflavin-T and its binding to amyloid fibrils: insights at the molecular level. , 2010, Chemical communications.

[18]  D. Klimov,et al.  Molecular dynamics simulations of Ibuprofen binding to Abeta peptides. , 2009, Biophysical journal.

[19]  C. Schein,et al.  Computational selection of inhibitors of Abeta aggregation and neuronal toxicity. , 2009, Bioorganic & medicinal chemistry.

[20]  A. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[21]  Y. Duan,et al.  The binding of thioflavin T and its neutral analog BTA-1 to protofibrils of the Alzheimer's disease Abeta(16-22) peptide probed by molecular dynamics simulations. , 2008, Journal of molecular biology.

[22]  Richard D. Leapman,et al.  Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[23]  J. Barton,et al.  Mechanism of cellular uptake of a ruthenium polypyridyl complex. , 2008, Biochemistry.

[24]  T. Jovin,et al.  Fluorescent N-arylaminonaphthalene sulfonate probes for amyloid aggregation of alpha-synuclein. , 2008, Biophysical journal.

[25]  B. Penke,et al.  Stepwise dynamics of epitaxially growing single amyloid fibrils , 2008, Proceedings of the National Academy of Sciences.

[26]  Y. Duan,et al.  Dual binding modes of Congo red to amyloid protofibril surface observed in molecular dynamics simulations. , 2007, Journal of the American Chemical Society.

[27]  Jacqueline K Barton,et al.  Methods to explore cellular uptake of ruthenium complexes. , 2007, Journal of the American Chemical Society.

[28]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[29]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[30]  Gerhard Hummer,et al.  Molecular dynamics simulations of Alzheimer's β-amyloid protofilaments , 2005 .

[31]  H. Levine Multiple ligand binding sites on A beta(1-40) fibrils. , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[32]  Chris Oostenbrink,et al.  A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force‐field parameter sets 53A5 and 53A6 , 2004, J. Comput. Chem..

[33]  Wei Zhang,et al.  A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..

[34]  M. K. Brennaman,et al.  Turning the [Ru(bpy)2dppz]2+ light-switch on and off with temperature. , 2002, Journal of the American Chemical Society.

[35]  C. Rabiner,et al.  Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer’s disease , 2002, Neuroscience.

[36]  Gert Vriend,et al.  Increasing the precision of comparative models with YASARA NOVA—a self‐parameterizing force field , 2002, Proteins.

[37]  Gert Vriend,et al.  Models@Home: distributed computing in bioinformatics using a screensaver based approach , 2002, Bioinform..

[38]  Berk Hess,et al.  GROMACS 3.0: a package for molecular simulation and trajectory analysis , 2001 .

[39]  G. Orellana,et al.  A Ruthenium Probe for Cell Viability Measurement Using Flow Cytometry, Confocal Microscopy and Time-resolved Luminescence¶ , 2000 .

[40]  D. Walsh,et al.  An improved method of preparing the amyloid β-protein for fibrillogenesis and neurotoxicity experiments , 2000, Neurobiology of Aging.

[41]  D. Odom,et al.  Recognition and reaction of metallointercalators with DNA. , 1999, Chemical reviews.

[42]  P. Lansbury,et al.  Synthesis and amyloid binding properties of rhenium complexes: preliminary progress toward a reagent for SPECT imaging of Alzheimer's disease brain. , 1999, Journal of medicinal chemistry.

[43]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[44]  Catherine J. Murphy,et al.  Dipyridophenazine complexes of Ru(II): versatile optical sensors for small and large molecules , 1997, Photonics West - Biomedical Optics.

[45]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[46]  S. Estus,et al.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing. , 1992, Science.

[47]  P. Kollman,et al.  Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models , 1992 .

[48]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[49]  N. Turro,et al.  Molecular light switch for DNA : Ru(bpy)2(dppz)2+ , 1990 .

[50]  Mikael Kubista,et al.  Experimental correction for the inner-filter effect in fluorescence spectra , 1994 .

[51]  E. Amouyal,et al.  Synthesis and study of a mixed-ligand ruthenium(II) complex in its ground and excited states: bis(2,2′-bipyridine)(dipyrido[3,2-a : 2′,3′-c]phenazine-N4N5)ruthenium(II) , 1990 .

[52]  C. Y. Huang Determination of binding stoichiometry by the continuous variation method: the Job plot. , 1982, Methods in enzymology.

[53]  L. A. Summers,et al.  Derivatives of 1,10-Phenanthroline-5,6-quinone , 1970 .